Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
40.60
-0.53 (-1.29%)
At close: Jul 15, 2026
Shanghai Serum Bio-Technology Company Description
Shanghai Serum Bio-Technology Co., Ltd. engages in research, development, production, operation, and sales of antitoxin and antivenom serum products for biotoxins and biosafety in China.
It offers equine anti-tetanus immunoglobulin, antivenom, and anti-rabies serum products. The company also engaged in the collection and sale of animal immune plasma.
The company was founded in 1999 and is based in Shanghai, China.
Shanghai Serum Bio-Technology Co., Ltd.
| Country | China |
| Founded | 1999 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 330 |
| CEO | Tiejiong Fan |
Contact Details
Address: No. 1288, Huaqing Road Shanghai, 201707 China | |
| Phone | 86 21 6076 0783 |
| Website | serum-china.com.cn |
Stock Details
| Ticker Symbol | 688163 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000059X8 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Tiejiong Fan | GM and Director |
| Liangjun Peng | Deputy GM, Core Technical Personnel and Director |
| Qiong Cheng | Deputy GM, Board Secretary and Director |
| Zhiping Zhang | Assistant to GM and Core Technical Personnel |
| Hao Zhang | General Manager Assistant |
| Jin Bao Liu | Financial Director |
| Binsheng Chen | Accounting Supervisor |